Recap - We’re in the throes of yet another sharp “V-bottom” for the S&P 500 (SPX), a rapid drop followed by a rip-your-face off rally – the 10th occurrence … Continue Reading
Read NowInsights - Agenus (AGEN) announced on Thursday that a shingles vaccine being developed by GlaxoSmithKline (GSK), and using a proprietary adjuvant licensed from AGEN, was succesful in … Continue Reading
Read NowInsights - Investor/entrepreneur Dr. Patrick Soon-Shiong is making a sizable investment in Sorrento Therapeutics (SRNE), in addition to forming a joint venture with the small company to develop … Continue Reading
Read NowzFree - 2014 has already been a year of M&A records in the biopharmaceutical industry, and on Monday December 8 yet another major transaction occurred, this time … Continue Reading
Read NowRecap - The American Society of Hematology’s annual meeting begins this weekend in San Francisco. It’s a big event for the oncology research community, particularly those studying blood cancers, … Continue Reading
Read NowInsights - Puma Biotech (PBYI) on Tuesday evening announced a significant, unexpected delay in its timeline for filing a New Drug Application with the FDA for lead … Continue Reading
Read NowInsights - Japanese drugmaker Otsuka Pharmaceutical Co. is buying US-based Avanir Pharmaceuticals (AVNR) for $3.5 billion, or $17/share, in a deal announced Tuesday morning. Despite a tremendous run … Continue Reading
Read Now
